GlassScriptPhysician profile
Ryan Allen Mcdermott
NPI 1114313301
$25,482.95
in general payments reported to CMS, 2019-2025
11 companies · $20K in 2025
The $20K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $684 · 2021: $422 · 2022: $1,589 · 2023: $315 · 2024: $2,378 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $8,231 · Food and Beverage: $1,903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,655.00 |
| Travel and Lodging | $8,230.78 |
| Food and Beverage | $1,903.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexxt Spine LLC | $19,600.58 | 2024-2025 | Expandable Lateral Cadaver Lab, Posterior Occipito-Cervico-Thoracic Project, Connexx Mis |
| Kyocera Medical Technologies, INC. | $2,125.00 | 2025 | |
| Abbott Laboratories | $1,719.57 | 2022-2025 | Proclaim |
| Medtronic USA, INC. | $683.51 | 2019 | |
| Medtronic, INC. | $309.36 | 2023-2025 | Osteocool Rf Ablation System, Cd Horizon Spinal System |
| Irras USA, INC. | $296.65 | 2021 | |
| Si-Bone, INC. | $275.05 | 2021-2025 | |
| Gt Medical Technologies, INC | $240.61 | 2023 | Gammatile |
| Centinel Spine, LLC | $152.23 | 2025 | Prodisc L |
| Orthofix Medical, INC. | $61.62 | 2024-2025 | Spinal-Stim, Cervical-Stim |
| Goode Surgical INC | $18.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mcdermott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.